Medicinal cannabis is one of the fastest growing areas of modern medicine — yet it remains widely misunderstood.

In this episode of The Revital Health Podcast, Jodi Duval speaks with Matt Shales, CEO and Co-Founder of MediCann Health, about the evolving medicinal cannabis industry in Australia and the science behind producing high-quality cannabis medicine.

Together they explore how cultivation, genetics, extraction methods, and rigorous testing all influence the safety and effectiveness of cannabinoid therapies.

The conversation moves beyond stigma and headlines to examine what truly defines a pharmaceutical-grade cannabis product and why quality control is critical for patient outcomes.

They also discuss the rapid expansion of medicinal cannabis prescribing in Australia, the role of clinical research, and the future of cannabinoid medicine.

In this episode we discuss:

How medicinal cannabis is grown and why genetics matter
The importance of cultivation methods and environmental control
Terpenes, cannabinoids, and the “entourage effect”
What defines a high-quality medicinal cannabis product
The challenges of regulation, stigma, and education
The future of cannabis research and clinical trials in Australia

This episode offers a fascinating insight into how a complex plant is being transformed into a regulated therapeutic medicine.

Connect with Matt Shales

Website

www.medicannhealth.com.au

Socials

Facebook: Medicann Health

LinkedIn: Medicann Health

Instagram: @medicannhealth